FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
Jana Spes
Advertisement
Jana Spes is Vice-President, Technical Operations, Apotex, jspes@apotex.com.
Articles by Jana Spes
Advertisement
Latest Updated Articles
Quality Metrics and CMO AgreementPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
